Research & development

JR Biomedical Ltd has an active R&D program for the development of new lateral flow rapid diagnostics for both clinical and self test use.

A pipeline of new SELFCheck products are planned and will be registered and released for sale during 2020-2021, doubling the number of products that were available in 2018 when JR Biomedical Ltd acquired 1st Health Products Ltd. A new point of care test for the early diagnosis of sepsis is under development with a UK university and will be launched for clinical use in Q1, 2021.

We are keen to collaborate with universities and pharmaceutical companies for the development of new in-vitro diagnostics.

Regular announcements regarding the progress of our research and development is posted on social media.